MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. (Q41412869)
Jump to navigation
Jump to search
scientific article published on 26 January 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. |
scientific article published on 26 January 2010 |
Statements
MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling (English)
Ka-Fai To
Nathalie Wong
Queenie W-L Wong
Arthur K-K Ching
26 January 2010